Price target

306.000.00 0.00%

The 7 analysts offering 1 year price forecasts for 3218 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings to 3218 in the past 3 months.

EPS

‪0.00‬

Reported

Estimate

Revenue

‪0.00‬

Reported

Estimate

Be warned

This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.

Frequently Asked Questions

3218 EPS for the last quarter is 2.99 TWD despite the estimation of 3.08 TWD. In the next quarter EPS is expected to reach 3.28 TWD. Track more of UNIVERSAL VISION BIOTECHNOLOGY CO financials and stay on top of what is up with the company.

In the next quarter UNIVERSAL VISION BIOTECHNOLOGY CO revenue is expected to reach ‪1.08 B‬ TWD. Check out UNIVERSAL VISION BIOTECHNOLOGY CO revenue and earnings and make informed decisions.

According to analysts, 3218 price target is 306.00 TWD with a max estimate of 350.00 TWD and a min estimate of 281.00 TWD. Check if this forecast comes true in a year, meanwhile watch UNIVERSAL VISION BIOTECHNOLOGY CO stock price chart and keep track of the current situation with 3218 news and stock market news.

We've gathered opinions of 7 analysts rating 3218 stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.